The PI3K/AKT/mTOR pathway was recently showed to reduce oxidative stress and promote cell survival of breast epithelial cells segregated from the ECM by strengthening flux through the oxidative PPP (195) PIK3CA mutation, which leads to increased PI3K activity, is the most common somatic mutation in breast cancer, and 36% of patients with HR+/HER2- breast cancer are PIK3CA mutated (196)
PubMed, Casetti, F., et al
Target molecules include CYP19A1, CYP11A1, CYP1A2, IRS-1, GLUT4, SIRT1, SIRT2, CXCL14, kisspeptin, CYP17A1, and Cox-2, while major signaling pathways include AMPK, PI3K/AKT, TGF-1/Smad, JAK2/STAT3, HMGB1/TLR4/NF-B, IRE1-XBP1, and SIRT1/PGC-1
Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system
La premire se traduit par une statorrhe (diarrhe graisseuse secondaire la maldigestion des graisses) et, la seconde, par un diabte